Endokrinologikum Frankfurt
- Address
- lock Available on a paid plan
Hormonal Diseases Research at Endokrinologikum Frankfurt
The site is involved in clinical research focused on hormonal diseases, with an emphasis on childhood growth disorders. Current studies are exploring new ways to support growth hormone-related care in children who need help growing, including those with short stature linked to specific medical conditions.
- Children with short stature caused by being born small for gestational age, Turner syndrome, Noonan syndrome, or idiopathic short stature
- Growth hormone deficiency in children
- Trials comparing a weekly treatment option with a daily standard therapy to evaluate growth outcomes and treatment effectiveness
This research aims to improve treatment convenience and assess whether newer options can deliver similar support for linear growth in pediatric patients.
Pediatric Growth Treatment Studies
Clinical trials at this health care site in Frankfurt are examining therapies for children with impaired growth. The research is centered on finding effective approaches for growth hormone deficiency and related conditions, with a focus on whether a newer weekly therapy can match established daily treatment.
- Short stature in children with SGA, Turner syndrome, Noonan syndrome, or idiopathic short stature
- Comparative studies of somapacitan and Norditropin® for pediatric growth support
- Evaluation of treatment effectiveness in children with low levels of growth-related hormone
Overall, the studies are designed to help clarify whether newer therapies can provide reliable growth benefits while potentially offering a simpler dosing schedule for families.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Endokrinologikum Frankfurt
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Study of Somapacitan and Somatropin on Growth Outcomes in Pediatric Growth Hormone Deficiency | Novo Nordisk A/S | Phase III | Not Recruiting | May 2019 | Sep 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Somapacitan | 1 | Unknown | 2019-05-29 | 2019-05-29 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.